Salesforce (NYSE:CRM) surpassed revenue expectations in Q3 CY2024 but fell short in profit and revenue guidance for the next quarter. Despite solid growth and financial performance, investors should consider long-term sales performance before buying Salesforce stock.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing